Breakthrough FDA Approval Secured By This Medical Company For Depressive Disorder

Cybin's Breakthrough: FDA Approval and Positive Durability Data for CYB003 in Major Depressive Disorder.

As an investor it's important to stay updated with major news. Get real-time stock market alerts, news, and research by creating an account here.

In a significant development for the mental health industry, Cybin Inc., an innovative biopharmaceutical company focused on psychedelic therapeutics, has announced two major breakthroughs. The U.S. Food and Dru…